Aziz Kabeer's most recent trade in AN2 Therapeutics Inc was a trade of 19,111 Stock Optin (Right to Buy) done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AN2 Therapeutics Inc | Kabeer Aziz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 19,111 | 19,111 | - | - | Stock Optin (Right to Buy) | |
| AN2 Therapeutics Inc | Kabeer Aziz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 9,705 | 18,677 | - | 0 | Common Stock | |
| AN2 Therapeutics Inc | Aziz Kabeer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 8,972 | 8,972 | - | 0 | Common Stock | |
| AN2 Therapeutics Inc | Kabeer Aziz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2024 | 64,503 | 64,503 | - | - | Stock Option (Right to Buy) | |
| AN2 Therapeutics Inc | Aziz Kabeer | Director | Sale of securities on an exchange or to another person at price $ 19.65 per share. | 16 Jan 2024 | 84,093 | 1,995,958 | - | 19.6 | 1,652,427 | Common Stock |
| AN2 Therapeutics Inc | Kabeer Aziz | Director | Sale of securities on an exchange or to another person at price $ 19.65 per share. | 16 Jan 2024 | 15,907 | 377,542 | - | 19.7 | 312,573 | Common Stock |
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 23 Aug 2023 | 336 | 2,183,888 | - | 16 | 5,376 | Common Stock |
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 23 Aug 2023 | 64 | 413,092 | - | 16 | 1,024 | Common Stock |
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | Other type of transaction at price $ 15.00 per share. | 06 Jun 2022 | 26,511 | 413,156 | - | 15 | 397,665 | Common Stock |
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | Other type of transaction at price $ 15.00 per share. | 06 Jun 2022 | 26,511 | 2,184,224 | - | 15 | 397,665 | Common Stock |
| AN2 Therapeutics Inc | Kabeer Aziz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 20,724 | 20,724 | - | - | Stock Option (right to buy) | |
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 1,651,636 | 1,651,636 | - | - | Common Stock | ||
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 1,651,636 | 0 | - | - | Series A Convertible Preferred Stock | ||
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 392,433 | 2,044,069 | - | - | Common Stock | ||
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 392,433 | 0 | - | - | Series B Convertible Preferred Stock | ||
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 312,415 | 312,415 | - | - | Common Stock | ||
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 312,415 | 0 | - | - | Series A Convertible Preferred Stock | ||
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 29 Mar 2022 | 166,666 | 2,210,735 | - | 15 | 2,499,990 | Common Stock |
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 74,230 | 386,645 | - | - | Common Stock | ||
| AN2 Therapeutics Inc | Kabeer Aziz | Director, Ten Percent Owner | 29 Mar 2022 | 74,230 | 0 | - | - | Series B Convertible Preferred Stock |